Yongin, South Korea

Sojung Lim

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Croda Korea Ltd. Active years: 2025.


% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sojung Lim: Innovator in Dermatologic Compositions

Introduction

Sojung Lim is a prominent inventor based in Yongin, South Korea. She has made significant contributions to the field of dermatology through her innovative research and development of novel compositions. Her work focuses on enhancing skin health and protection.

Latest Patents

Sojung Lim holds a patent for a novel sphingolipid and a dermatologic composition comprising the same for external application. This innovative sphingolipid is in liquid form at room temperature due to its low melting point, allowing it to blend easily with various vegetable and animal oils. The dermatologic composition containing this sphingolipid is designed to provide anti-inflammatory protection, improve moisturization, protect the skin from ultraviolet (UV) light, and enhance skin barriers. She has 1 patent to her name.

Career Highlights

Sojung Lim is currently associated with Croda Korea Ltd., where she continues to advance her research in dermatologic applications. Her work has garnered attention for its potential to improve skin health and provide effective solutions for various dermatological issues.

Collaborations

Sojung Lim collaborates with talented individuals in her field, including her coworkers Youngbeom Kim and Daebang Seo. Their combined expertise contributes to the innovative projects at Croda Korea Ltd.

Conclusion

Sojung Lim is a trailblazer in the development of dermatologic compositions, with her innovative sphingolipid patent showcasing her commitment to enhancing skin health. Her contributions are paving the way for future advancements in dermatology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…